Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Integrated Cannabis Company, Inc. Signs Distribution Agreement with Empower Clinics, Inc.


Posted on: 20 Sep 18

VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis”), is pleased to announce the completion of a Letter of Intent (LOI) to distribute X-SPRAYS™ products throughout the clinics and doctors’ offices of Empower Clinics Inc. (CSE: EPW; FRA: 8EC) (“Empower”), a leading owner and operator of medical cannabis and wellness clinics in the United States (US).

The companies have recently engaged with their marketing and distribution teams to streamline the logistics of rolling out new products in the Empower clinics. Integrated Cannabis will distribute all of its CBD-infused X-SPRAYS™ including; CBD, Sleep, Recover, Libido and Energy throughout the Empower ecosystem.

“We believe this milestone marks another significant move for distribution of X-SPRAYS™ in key markets across the United States. In addition, we believe this alliance will help increase awareness from credible sources about alternative treatments for those struggling with opioid addiction, pain, anxiety, sleep issues and people seeking overall well-being,” said Mr. John Knapp, CEO of Integrated Cannabis. The Company expects to sign a definitive agreement with Empower in the coming weeks.

“We are very excited about our partnership with X-SPRAYS as we believe it brings leading technology and treatment for the most common conditions our patients face. X-SPRAYS state of the art product formulations and unique metered dosage help consistently deliver a world class product,” said Mr. Craig Snyder, CEO of Empower.

As of August 31, Empower has more than 25,000 patients under care across 15 locations with medical cannabis treatments in Oregon, Washington and Illinois. The patient base in Oregon represents approximately one-third of the state’s total medical card issuance. In addition, Empower has an historical patient database of more than 120,000 in the two states.

On September 12, Empower announced the opening of its flagship Chicago clinic. In Illinois, the company seeks to expand its operations and achieve a leadership position as it executes on parallel national clinic and product strategies. There is currently an opioid epidemic in the United States and the company’s announced Chicago facility closely followed the endorsement by Illinois Governor Bruce Rauner of medical cannabis as a frontline treatment and alternative for patients with a new statewide measure he signed into law on Aug 28.

ABOUT EMPOWER
Empower is a leading owner and operator of medical cannabis and wellness clinics, as well as a developer of medical products in the US, focused on enabling individuals to improve and protect their health. The company provides treatment solutions through its physician-staffed clinics that are focused on education, data, and efficacy. Empower is a recognized leader and the first choice for patients seeking quality experience and improved health.

About Integrated Cannabis Company
Integrated Cannabis Company, Inc. is comprised of dedicated scientists and product engineers who are passionate about health and creating health and lifestyle products utilizing advanced delivery systems and formulations. For more information, please visit the company’s website at: www.x-sprays.com.

ON BEHALF OF THE BOARD

“John Knapp”
Chief Executive Officer

For further information, please contact:
Telephone: 778-403-3358
Email: info@cnrpmining.com 

The CSE does not accept responsibility for the adequacy or accuracy of this release. 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

 

GlobeNewswire
globenewswire.com

Last updated on: 20/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.